Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Colon to Rectum

    Effect of induction therapy with olamkicept versus placebo on clinical response in patients with active ulcerative colitis: A randomized clinical trial

    JAMA. 2023;329(9):725−34

    Zhang S, Chen B, Wang B, Chen H, Li Y, Cao Q, Zhong J, Shieh MJ, Ran Z, Tang T, Yang M, Xu B, Wang Q, Liu Y, Ma L, Wang X, Zhang N, Zhang S, Guo W, Huang L, Schreiber S, Chen M

    Go to article

    Colon to Rectum

    The risk of serious infections before and after anti-TNF therapy in inflammatory bowel disease: A retrospective co-hort study

    Inflamm Dis. 2023;29(3):339−48

    Holmgren J, Fröborg A, Visuri I, Halfvarson J, Hjortswang H, Karling P, Myrelid P, Olén O, Ludvigsson JF, Grip O; SWIBREG study group

    Go to article

    Colon to Rectum

    Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic

    United European Gastroenterol J. 2023;11(4):361−70

    Bonsack O, Caron B, Baumann C, Heba AC, Vieujean S, Arnone D, Netter P, Danese S, Quilliot D, Peyrin-Biroulet L

    Go to article

    Colon to Rectum

    Efficacy and safety of colesevelam for the treatment of bile acid diarrhea: A double-blind, randomized, place-bo-controlled, phase 4 clinical trial

    Lancet Gastroenterol Hepatol. 2023;8(4):321−31

    Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, Zaremba A, Borup Andersen T, Nøjgaard C, Timm HB, Rainteau D, Hansen SH, Rumessen JJ, Munck LK

    Go to article

    Colon to Rectum

    Randomized, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhea: The TRITON trial

    Aliment Pharmacol Ther. 2023;57(11):1258−71

    Gunn D, Topan R, Barnard L, Fried R, Holloway I, Brindle R, Corsetti M, Scott M, Farmer A, Kapur K, Sanders D, Eugenicos M, Trudgill N, Whorwell P, Mclaughlin J, Akbar A, Houghton L, Dinning PG, Aziz Q, Ford AC, Farrin AJ, Spiller R

    Go to article

    Colon to Rectum

    Linaclotide reduced response time for irritable bowel syndrome with constipation symptoms: Analysis of 4 ran-domized controlled trials

    Am J Gastroenterol. 2023;118(5):872−9

    Brenner DM, Lacy BE, Ford AC, Bartolini W, Wu J, Shea EP, Bochenek W, Boinpally R, Almansa C

    Go to article

    Colon to Rectum

    Randomized placebo-controlled phase 3 trial of vibrating capsule for chronic constipation

    Gastroenterology. 2023;164(7):1202−10.e6

    Rao SSC, Quigley EMM, Chey WD, Sharma A, Lembo AJ

    Go to article

    Colon to Rectum

    Trifluridine-tipiracil and bevacizumab in refractory metastatic colorectal cancer

    N Engl J Med. 2023;388(18):1657–67

    Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators

    Go to article

    Colon to Rectum

    Preoperative chemotherapy for operable colon cancer: Mature results of an international randomized controlled trial

    J Clin Oncol. 2023;41(8):1541−52

    Morton D, Seymour M, Magill L, Handley K, Glasbey J, Glimelius B, Palmer A, Seligmann J, Laurberg S, Murakami K, West N, Quirke P, Gray R; FOxTROT Collaborative Group

    Go to article